Attached files

file filename
S-1/A - FORM S-1/A - H-CYTE, INC.mdvxs1a2_nov2014.htm
EX-1.2 - FORM OF UNDERWRITER'S WARRANT AGREEMENT, AS AMENDED. - H-CYTE, INC.ex1-2.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT, AS AMENDED. - H-CYTE, INC.ex1-1.htm
Exhibit 23.1
 
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS CONSENT
 
We consent to the inclusion in this Registration Statement of Medovex Corp. and subsidiary on Form S-1 Amendment No. 2 (File No. 333-198621) of our report dated May 1, 2014 except for Notes 2 and 9, and paragraph 2 of Note 6, as to which the date is September 5, 2014, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern and an emphasis of matter paragraph related to a restatement of the consolidated financial statements, with respect to our audit of the consolidated financial statements of Medovex Corporation and Subsidiary as of December 31, 2013 and consolidated statements of operations, changes in stockholders equity and cash flows for the period from February 1, 2013 (inception) to December 31, 2013, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading "Experts" in such Prospectus.
 
/s/ Marcum LLP
 
New York, NY
November 11, 2014